Loading
Cases by country, the UK and NHS pathway and other country lenses, the expert centres with trials on record, and the centres named on this cancer's subtypes.
No country-level case numbers. This cancer is not mapped to a GLOBOCAN site.
Baltimore · cancer center | United States | 0 | 2,962 | 42,161 | #10 | ||
Milan · cancer center | Italy | none recorded | 0 | 1,282 | 18,091 | #27 | |
Guangzhou · hospital | China | none recorded | 0 | 1,245 | 12,931 | - | |
Lausanne · hospital | Switzerland | none recorded | 0 | 838 | 14,951 | - | |
Brussels · cancer center | Belgium | none recorded | 0 | 489 | 8,689 | - | |
Rosemont, IL · consortium | United States | none recorded | 0 | 49 | 750 | - | |
Prague · consortium | Czechia | none recorded | 0 | not matched | - | - | |
Brussels · consortium | Belgium | none recorded | 0 | not matched | - | - |
These are the things we can measure; they are not a ranking of quality. Each column is a field on the institution record or a count over what OnCo has linked; a centre that treats many patients with Appendiceal adenocarcinoma but is thinly recorded here will look small.
Not known: OnCo holds no case-volume or outcome figures for centres, so none are shown. Where a national audit or registry publishes them, the centre's page links to it. Default order: Newsweek rank, then trials for this cancer, then research output.